Molecular mechanisms of HIV-1 protease resistance and resensitization towards lopinavir and saquinavir upon L76V mutation

被引：0
|
作者：
Bastys, T. [1 ]
Doncheva, N. T. [1 ]
Walter, H. [2 ]
Kaiser, R. [3 ]
Albrecht, M. [4 ,5 ]
Kalinina, O. V. [1 ]
机构：
[1] Max Planck Inst Informat, D-66123 Saarbrucken, Germany
[2] MIB, Berlin, Germany
[3] Univ Hosp Cologne, Inst Virol, Cologne, Germany
[4] Univ Med Greifswald, Greifswald, Germany
[5] Graz Univ Technol, A-8010 Graz, Austria
来源：
ANTIVIRAL THERAPY | 2014年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
108
引用
收藏
页码：A154 / A154
页数：1
相关论文
共 50 条
  • [41] Understanding Drug Resistance of Wild-Type and L38HL Insertion Mutant of HIV-1 C Protease to Saquinavir
    Venkatachalam, Sankaran
    Murlidharan, Nisha
    Krishnan, Sowmya R.
    Ramakrishnan, C.
    Setshedi, Mpho
    Pandian, Ramesh
    Barh, Debmalya
    Tiwari, Sandeep
    Azevedo, Vasco
    Sayed, Yasien
    Gromiha, M. Michael
    GENES, 2023, 14 (02)
  • [42] Mechanisms associated with HIV-1 resistance to acyclovir by the V75I mutation in reverse transcriptase
    Tchesnokov, E. P.
    Obikhod, A.
    Massud, I.
    Lisco, A.
    Vanpouille, C.
    Brichacek, B.
    Balzarini, J.
    McGuigan, C.
    Derudas, M.
    Margolis, L.
    Schinazi, R. F.
    Goette, M.
    ANTIVIRAL THERAPY, 2009, 14 (04) : A21 - A21
  • [43] Drug resistance of HIV-1 protease against JE-2147:I47V mutation investigated by molecular dynamics simulation
    Bandyopadhyay, P
    Meher, BR
    CHEMICAL BIOLOGY & DRUG DESIGN, 2006, 67 (02) : 155 - 161
  • [44] Mechanisms Associated with HIV-1 Resistance to Acyclovir by the V75I Mutation in Reverse Transcriptase
    Tchesnokov, Egor P.
    Obikhod, Aleksandr
    Massud, Ivana
    Lisco, Andrea
    Vanpouille, Christophe
    Brichacek, Beda
    Balzarini, Jan
    McGuigan, Christopher
    Derudas, Marco
    Margolis, Leonid
    Schinazi, Raymond F.
    Goette, Matthias
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (32) : 21496 - 21504
  • [45] Molecular basis of resistance to HIV-1 protease inhibition:: A plausible hypothesis
    Luque, I
    Todd, MJ
    Gómez, J
    Semo, N
    Freire, E
    BIOCHEMISTRY, 1998, 37 (17) : 5791 - 5797
  • [46] Molecular tridimensional phenotyping predicts HIV-1 protease inhibitor resistance
    Pèpe, G
    Courcambeck, J
    Durant, J
    Dellamonica, P
    Boulme, R
    Halfon, P
    ANTIVIRAL THERAPY, 2002, 7 : S117 - S117
  • [47] Atomic resolution crystal structures of HIV-1 protease and mutants V82A and I84V with saquinavir
    Tie, Yunfeng
    Kovalevsky, Andrey Y.
    Boross, Peter
    Wang, Yuan-Fang
    Ghosh, Arun K.
    Tozser, Jozsef
    Harrison, Robert W.
    Weber, Irene T.
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2007, 67 (01) : 232 - 242
  • [48] Clinical cross-resistance between the HIV-1 protease inhibitors saquinavir and indinavir and correlations with genotypic mutations
    Schapiro, JM
    Winters, MA
    Lawrence, J
    Merigan, TC
    AIDS, 1999, 13 (03) : 359 - 365
  • [49] The HIV-1 protease resistance mutation I50L is associated with resistance to atazanavir and susceptibility to other protease inhibitors in multiple mutational contexts
    Sista, P.
    Wasikowski, B.
    Lecocq, P.
    Pattery, T.
    Bacheler, L.
    JOURNAL OF CLINICAL VIROLOGY, 2008, 42 (04) : 405 - 408
  • [50] Analyses of accessory mutations in HIV-1 protease reveal interdependent mechanisms of resistance
    Ragland, D. A.
    Nalam, M. N. L.
    Ozen, A.
    Cai, Y.
    Cao, H.
    Schiffer, C. A.
    ANTIVIRAL THERAPY, 2014, 19 : A155 - A155
12345